Company / SG&A per Share
C4 Therapeutics, Inc. SG&A per Share History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$0.51
FY2025
5-year range
$0.51 / $0.86
FY2022-FY2025
Trend
-26.4%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $0.86 to $0.51 over the past 2 years.
Based on SEC 10-K filings.
0.51 in FY2025 with a 3-year CAGR of -9.1%.
Improved from $0.86 to $0.51 over the past 2 years.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- -9.1%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, sg&a per share decreased 26.4% year-over-year.
Company context
Key Data Points
- Altman Z-Score -1.14 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.51 | -26.4% |
| FY2024 | $0.70 | -19.0% |
| FY2023 | $0.86 | +25.8% |
| FY2022 | $0.68 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026